0001127602-23-015029.txt : 20230509
0001127602-23-015029.hdr.sgml : 20230509
20230509170250
ACCESSION NUMBER: 0001127602-23-015029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230508
FILED AS OF DATE: 20230509
DATE AS OF CHANGE: 20230509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Deschatelets Pascal
CENTRAL INDEX KEY: 0001657720
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 23903154
MAIL ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-05-08
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001657720
Deschatelets Pascal
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
Chief Scientific Officer
1
Common Stock
2023-05-08
4
M
0
18500
2.67
A
1045813
D
Common Stock
2023-05-08
4
S
0
12000
92.39
D
1033813
D
Stock Option (Right to Buy)
2.67
2023-05-08
4
M
0
18500
0
D
2023-12-05
Common Stock
18500
109994
D
This is a scheduled exercise and sale from a 10B5-1 trading plan.
This stock option was granted on 12/5/2013 and is fully vested.
/s/ David Watson, attorney-in-fact for Pascal Deschatelets
2023-05-09